Oligodeoxynucleotides containing palindrome sequences with internal 5'-CpG-3' act directly on human NK and activated T cells to induce IFN-gamma production in vitro

J Immunol. 1999 Oct 1;163(7):3642-52.

Abstract

Previous studies have shown that the action of bacterial or synthetic oligodeoxynucleotide (oligo-DNA) on mouse NK cells to produce IFN-gamma is mediated mostly by monocytes/macrophages activated by olig-DNA. However, its action on human IFN-gamma-producing cells has not been well investigated. In the present study, we examined the effect of oligo-DNAs on highly purified human NK and T cells. Bacillus Calmette-Guérin-derived or synthetic oligo-DNAs induced NK cells to produce IFN-gamma with an increased CD69 expression, and the autocrine IFN-gamma enhanced their cytotoxicity. The response of NK cells to oligo-DNAs was enhanced when the cells were activated with IL-2, IL-12, or anti-CD16 Ab. T cells did not produce IFN-gamma in response to oligo-DNAs but did respond independently of IL-2 when they were stimulated with anti-CD3 Ab. In the action of oligo-DNAs, the palindrome sequence containing unmethylated 5'-CpG-3' motif(s) appeared to play an important role in the IFN-gamma-producing ability of NK cells. The changes of base composition inside or outside the palindrome sequence altered its activity: The homooligo-G-flanked GACGATCGTC was the most potent IFN-gamma inducer for NK cells. The CG palindrome was also important for activated NK and T cells in their IFN-gamma production, although certain nonpalindromes acted on them. Among the sequences tested, cell activation- or cell lineage-specific sequences were likely; i.e., palindrome ACCGGT and nonpalindrome AACGAT were favored by activated NK cells but not by unactivated NK cells or activated T cells. These results indicate that oligo-DNAs containing CG palindrome act directly on human NK cells and activated T cells to induce IFN-gamma production.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adjuvants, Immunologic / pharmacology
  • Antibodies, Monoclonal / pharmacology
  • Antigens, CD / biosynthesis
  • Antigens, Differentiation, T-Lymphocyte / biosynthesis
  • Cell Separation
  • Cells, Cultured
  • CpG Islands / immunology*
  • Cytokines / physiology
  • Cytotoxicity, Immunologic / drug effects
  • Cytotoxicity, Immunologic / genetics
  • DNA, Bacterial / chemical synthesis
  • DNA, Bacterial / pharmacology
  • Humans
  • Interferon-gamma / biosynthesis*
  • Interferon-gamma / physiology
  • Interleukin-12 / pharmacology
  • Interleukin-2 / pharmacology
  • Killer Cells, Natural / immunology
  • Killer Cells, Natural / metabolism*
  • Lectins, C-Type
  • Lymphocyte Activation* / drug effects
  • Lymphocyte Activation* / genetics
  • Macrophages / metabolism
  • Monocytes / metabolism
  • Mycobacterium bovis / genetics
  • Oligodeoxyribonucleotides / chemical synthesis
  • Oligodeoxyribonucleotides / pharmacology*
  • Receptors, IgG / immunology
  • Repetitive Sequences, Nucleic Acid / immunology
  • T-Lymphocytes / immunology
  • T-Lymphocytes / metabolism*

Substances

  • Adjuvants, Immunologic
  • Antibodies, Monoclonal
  • Antigens, CD
  • Antigens, Differentiation, T-Lymphocyte
  • CD69 antigen
  • Cytokines
  • DNA, Bacterial
  • Interleukin-2
  • Lectins, C-Type
  • Oligodeoxyribonucleotides
  • Receptors, IgG
  • Interleukin-12
  • Interferon-gamma